Unmatched Expertise in DMC Oversight for 20+ Years
Advarra provides the resources and expertise to assemble, charter, and manage your DMC within any therapeutic area, anywhere on the globe. As a third-party services provider, our goal is to facilitate the safety oversight of trial participants, ensure security of patient data and integrity of clinical trial results, while working closely with your clinical trial team to adhere to country-specific regulations.
Manager Spotlight

Barbara Schneider, PhD, MBA
Executive Director, Biostatistical Services
Dr. Barbara Schneider heads Advarra’s independent data monitoring committee and endpoint adjudication services, which have provided trusted safety oversight for clinical trials since 2002. Prior to joining Advarra, Dr. Schneider was the founder and CEO of Watermark Research Partners. Watermark was one of the first companies to provide independent data safety monitoring board (DSMB) services and endpoint adjudication to the clinical trial industry. (Watermark joined Advarra in 2021.)

James Riddle, MCSE, CIP, CPIA, CRQM
Senior Vice President, Global Review Operations
James Riddle brings 25+ years of experience providing support to the clinical research community and oversees all of Advarra’s global review services including IRB, IBC, DMC, EAC. In this role, he helps sponsors, CROs, and research sites advance clinical research with a mission to improve human health. His expertise includes developing and operationalizing processes for maximum efficiency, client satisfaction, and participant protection; development and implementation of technology solutions; and efficient, compliant operation of large clinical research review programs. Riddle is a regular speaker at industry events and has written abundantly on research compliance and efficiency topics. He is also a member of CTTI, NWABR, SASI, and PRIM&R.
Featured Content

Frequently Asked Questions
Explore our comprehensive FAQ page for detailed answers to questions about our IRB, IBC, DMC, and EAC services.